Digital Transformation

This evolution of healthcare involves using technology to improve diagnosis, treatments, monitor patients, enhance hospital operations and culture, and bolster consumer-focused care. This includes virtual reality tools, wearable devices, workflow software, health apps and other digital health tools.

Thumbnail

Bon Secours Mercy Health launches digital holding company

The new company, Accrete Health Partners, will act as an investment arm in the company’s digital health services interests and partnerships.

DOJ now investigating Cerebral for ADHD prescribing practices

As a result, the company stated it will pause the practice of prescribing controlled substances as a treatment for ADHD such as Adderall and Ritalin for new patients starting May 9.

Hello Heart raises $70M as digital therapeutics demand soars

Hello Heart, a digital therapeutics company that focuses on heart health, has raised $70 million in a Series D funding round.

Thumbnail

CVS: Mental health concerns are rising

Nearly 6 in 10 Americans (59%) have experienced concerns about either their own mental health or that of family and friends.

 

Thumbnail

Walmart launches telehealth diabetes program

The program is run by MeMD, a telehealth provider Walmart acquired last year.

NASA holoportation

NASA beams doctor virtually into space

Telemedicine boomed in popularity during the COVID-19 pandemic, but remote healthcare isn’t just for homebound patients––it’s also now available to astronauts.

Vytalize Health raises $50 million in funding to expand senior care

Vytalize Health, a value-based care platform for seniors, has raised $50 million from investors in a Series B funding round.

 

Thumbnail

Advocate Aurora acquires MobileHelp

Advocate Aurora Enterprises, the investment arm of Wisconsin- and Illinois-based health system Aurora Advocate, has acquired remote patient monitoring provider MobileHelp. 

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.